Related Experiment Video
Updated: Sep 13, 2025

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
Biliary Complications and Management After Liver Transplantation
Tufan Egeli1, Ibrahim Kemal Astarcioglu2, Tarkan Unek1
1General Surgery, Dokuz Eylul University Medical Faculty, Izmir, Turkiye.
Biliary complications (BC) affect 8.2% of liver transplant (LT) patients, with living donor LT and prolonged cold ischemia time (CIT) as key risk factors. Early intervention and strict selection can mitigate these challenges.
Area of Science:
- Hepatology
- Transplant Surgery
- Gastroenterology
Background:
- Biliary complications (BC) remain a significant challenge after liver transplantation (LT).
- Understanding the risk factors and effective management strategies for BC is crucial for improving patient outcomes.
Purpose of the Study:
- To determine the incidence, causes, and treatment of BC following LT.
- To identify risk factors associated with BC development, including donor and recipient characteristics, graft type, and surgical factors.
- To analyze treatment modalities, morbidity, and mortality rates associated with BC.
Main Methods:
- Retrospective analysis of 590 adult patients undergoing LT between February 1997 and 2024.
- Exclusion of patients with early postoperative mortality or spontaneous bile drainage regression.
- Evaluation of incidence, types of BC, and associations with recipient/donor factors, graft characteristics, cold ischemia time (CIT), and biliary reconstruction techniques.
Main Results:
- BC occurred in 8.2% of patients (49/590).
- Living donor LT and prolonged CIT were significant risk factors for BC in the overall cohort (P ≤ .001).
- In cirrhosis-specific LT, living donor transplantation (P = .001), prolonged CIT (P ≤ .001), and viral etiology (P = .046) were associated with BC. Mortality due to BC was 38.7%.
Conclusions:
- Biliary complications continue to pose a significant challenge in liver transplantation.
- Identifying and mitigating risk factors, alongside strict patient selection, can reduce BC incidence.
- A multidisciplinary approach is effective for managing BC in most liver transplant recipients.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Kidney Transplant III: Nursing Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

